Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find enclosed the transcript of the earnings conference call for the quarter ended Juen 30, 2023.14-08-2023
14-08-2023
Suven Pharmaceuticals Ltd - 543064 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for UTI Mutual Fund & PACs11-08-2023
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our Results conference call intimation dated August 10, 2023, that audio recording of the conference call for the quarter ended June 30, 2023 held on Thursday, August 10, 2023, has been uploaded on the Company''s website at https://suvenpharm.com/financial-info/ This is for your information and record.11-08-2023
Suven Pharmaceuticals Results Earnings Call for Q1FY24
Conference Call with Suven Pharmaceuticals Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.10-08-2023
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to regulation 47 of SEBI (LODR), please find enclosed copies of news paper advertisements regarding Financial Results of the Company for the quarter ended June 30, 2023. The advertisements has appeared in today i.e., August 09, 2023 in Andhra Prabha (Telugu) and Business Standard.09-08-2023
Suven Pharma gains on healthy Q1 show, strong operational performance
The highlight of Suven Pharma's Q1 earnings was the company's sharp margin improvement09-08-2023
Suven Pharmaceuticals Ltd - 543064 - Outcome Of The Board Meeting-Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June, 2023
we wish to inform you that the Board of Directors of the company, at its meeting held today i.e. August 8, 2023, has taken on record and apporved the attached Un-audited Standalone and Conslidated Financial Results of the Company prepared under IND AS for the quarter ended 30th June, 2023 along with Limited Reveiw Reports of the Staturoty Auditors.08-08-2023
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to above subject, please find enclosed herewith an invitation for conducting the conference call for investors on Thursday, August 10, 2023 at 1:00 pm IST to discuss the Un-audited Financial Results for the Q1 FY24, to be declared on August 8, 2023.07-08-2023
Suven Pharmaceuticals Ltd - 543064 - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Tuesday, The 8Th August, 2023
Suven Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2023 ,inter alia, to consider and approve With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Tuesday, the 8th August, 2023 at 3:00 p.m. at the Registered Office, SDE Serene Chambers, 3rd Floor, Road No 5, Banjara Hills, Hyderabad - 500034 of the Company, to consider, inter alia, and approve the following matter(s): To consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the first quarter ended June 30, 2023 and related matters. Please further note that TRADING WINDOW for dealing in the securities of the company is already closed from 01st July, 2023 as per PIT Code of the Company. Trading window will be opened from 11th August, 2023.01-08-2023
Suven Pharmaceuticals Ltd - 543064 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, please find enclosed herewith the Confirmation certificate issued by KFin technologies Limited, Registrar and Share Transfer Agents of the Company, for the quarter ended June 30, 2023. This is for your information and record.06-07-2023